Medical Detox in Oregon
Composite analysis
Treatment Access Pressure Index
Oregon sits in the top quarter of states for treatment access pressure. Demand signals are elevated and verified provider supply is thin relative to population.
TAPI is a CCIWA composite. Each input is z-scored across 50 states plus DC and Puerto Rico, then combined as a weighted sum (HPSA 30%, frequent mental distress 25%, unemployment 15%, treatment density 30%, sign-flipped). The result is rescaled 0 to 100 by percentile rank. Read the full methodology.
Detox alone has a dismal track record for opioid use disorder. The reason is biological, not motivational. Once tolerance drops, relapse risk during the first two weeks after discharge is the highest of any window in the disease. Oregon runs a Medicaid program with variable MOUD coverage, which means the state has the medication infrastructure to bridge from detox into real treatment if a program chooses to use it.
What changes by state
| Factor | Oregon |
|---|---|
| Medicaid covers methadone | Unclear |
| Medicaid covers buprenorphine | Unclear |
| Medicaid covers residential SUD | Unclear |
| 1115 SUD waiver | None |
| IMD exclusion status | Standard IMD exclusion applies |
What to ask any Oregon detox program
The five questions on our detox overview page apply everywhere, but two of them tighten up here based on what Oregon Medicaid actually pays for. If buprenorphine is not started before discharge, that is a major clinical red flag. If a program tells you methadone is "not allowed" during detox, that is incorrect under federal rule and worth a second opinion.
If you have already detoxed
The single highest-leverage move after detox is a same-week MOUD appointment. Oregon OTPs can induct same day or next day in most cases. Buprenorphine prescribers in Oregon can often do an in-office induction within 48 hours.
For the full coverage breakdown including prior authorization rules and continuity of care obligations, see the Oregon insurance guides are coming soon.